Articles
Trigger explainers, methodology notes, and category analysis. Primary-source citations on every clinical claim.
Article · August 7, 2026
Rosacea and migraine co-occur at elevated rates and share a nerve signal called CGRP. Two care teams, one patient, zero shared data. A combined log is the first document that shows it.
Article · August 6, 2026
Most trigger logs assume a flare shows up the same day you slipped. No published data says it does, and a daily diary can't see a trigger from two days back.
Article · August 5, 2026
On deeper skin tones flushing reads dusky purple or brown, not red, and fades without a trace. That makes a timestamped photo log diagnostically load-bearing, not optional.
Article · August 4, 2026
Central heating compresses two known rosacea triggers, heat and dry air, into the room where you spend most of your day, and a standard trigger diary never records it.
Article · August 3, 2026
Niacinamide and niacin share a name and a vitamin family, not a flushing pathway. When your trigger log blames one, it usually caught the other.
Article · July 31, 2026
The 'menopause resolves rosacea' story skips the hardest part: the years before, when estrogen swings and flushing often first appears. Almost no one is logging that window.
Article · July 30, 2026
Rosacea has no lab test, so the diagnosis comes from your photo record. Three decisions turn a chaotic camera roll into a log a dermatologist can classify in one visit.
Article · July 29, 2026
Steroid creams like hydrocortisone flatten facial redness fast, but they quietly corrupt the baseline a dermatologist needs to read your rosacea correctly.
Article · July 28, 2026
Rosacea topicals come with a built-in trial period before your dermatologist decides they worked. Almost nobody tells you what to record while it runs.
Article · July 27, 2026
Told to avoid retinoids because you have rosacea? That instruction collapses four very different compounds into one bucket, and the evidence pulls them apart.
Article · July 24, 2026
Rosacea has no confirmatory test. A dermatologist reads it from visible phenotype features, which means a timestamped photo series is the only objective record you can actually hand them.
Article · July 23, 2026
They share the same cheek-and-chin pustules. Five loggable variables tell them apart, and a four-week log is what your dermatologist actually needs to call it.
Article · July 22, 2026
The standard advice is to compare your face against rosacea photos online. For medium and deeper skin tones, that comparison quietly sends people away from a diagnosis they may need.
Article · July 21, 2026
Rhinophyma, the nose-thickening rosacea outcome that needs surgery, is almost entirely a men's disease. So is the diagnosis delay that makes it worse.
Article · July 20, 2026
Any start, stop, or switch of a hormonal contraceptive resets your rosacea baseline. Log the date, or spend the next two months blaming the wrong moisturizer.
Article · July 17, 2026
Rosacea and cardiovascular risk markers keep co-occurring in population cohorts because they share one inflammatory biology. That shared fire is why your worst flare weeks track illness and stress, not lunch.
Article · July 16, 2026
Why the same glass of wine flares you on Saturday but not Tuesday, and why single-trigger elimination logs give false answers about half the time.
Article · July 15, 2026
Dermatologists grade rosacea 0 to 4 on the IGA scale at every visit, and that number drives coverage and treatment escalation. Most patients never learn their own.
Article · July 14, 2026
"Sensitive skin" has no medical code and no treatment pathway. Rosacea has both. Here's why the difference can quietly cost years in the wrong aisle.
Article · July 13, 2026
You write 'really red, bad week.' Your dermatologist charts erythema grade and papule counts. The translation gap is where your best data disappears.
Article · July 10, 2026
Trigger lists name heat, wine, and sun. They skip the eight hours where circulating inflammation and barrier repair actually reset your skin's flushing threshold.
Article · July 9, 2026
Burning is the primary symptom for 94.75% of rosacea patients, yet the grading scale clinicians use to score severity has no line for it, and that gap costs you at your next appointment.
Article · July 8, 2026
Prior authorization for rosacea topicals gets denied on thin records. A timestamped photo and trigger log is the objective evidence payers actually ask for.
Article · July 7, 2026
Two people with identical SPF 50 compliance can flare in opposite directions. The number on the bottle can't tell them apart. The vehicle chemistry can.
Article · July 6, 2026
Rosacea is episodic, so the redness and bumps a dermatologist most needs to see usually fade before exam day. Here is the evidence packet to capture first.
Article · July 5, 2026
On a US label, 'fragrance-free' only means no ingredient called 'fragrance.' Essential oils and masking agents slip through under their own names, and your flare log never sees them.
Article · July 5, 2026
Topical brimonidine can leave your face redder than baseline once it wears off. That rebound flush is a timing pattern, not treatment failure, and a timestamped log tells them apart.
Article · July 5, 2026
Heat and heavy exercise trigger rosacea through one mechanism: thermoregulatory vasodilation. That makes ambient temperature, time of day, and exercise type tunable variables, not a binary you must avoid.
Article · July 5, 2026
Premenstrual rosacea flares look like random lifestyle triggers because most diaries never log the one variable that explains them: the day of your cycle.
Article · July 5, 2026
Stress flares run on the same nerve pathway as a hot drink, but rosacea diaries have no field for them, so they corrupt every trigger you try to isolate.
Article · June 26, 2026
Eye symptoms affect most rosacea patients and sometimes arrive first, but the specialty split means two doctors treat half the condition each, with no shared record between them.
Article · June 23, 2026
Heat, stress, red wine, and exercise feel like unrelated rosacea triggers. The mechanism says they all flip one nerve circuit, and that changes what is worth tracking.
Article · June 19, 2026
Dermatology retired the four-subtype model in 2017. Here is why 'which subtype am I?' sends rosacea patients down the wrong path, and what to track instead.
Article · June 15, 2026
Every clinical authority recommends documenting your rosacea before treatment. None of them specify the documentation standard a dermatologist can actually read. Here is what that standard looks like.
Article · June 11, 2026
Rosacea's signs appear and resolve, so a visit booked weeks after a flare often captures a calm face. The record you bring matters more than the exam.
Article · June 8, 2026
Trigger lists describe crowds, not faces. The only study that can find your rosacea triggers is the one you run on yourself.
Article · June 4, 2026
Meta-analysis ties rosacea to gut disturbances like SIBO. That is a replicated signal, not the probiotic-cure story circulating on Reddit. Here is where the evidence actually stops.
Article · May 28, 2026
Roughly 16 million Americans have rosacea. The category for tools that help them track it is one of the largest underbuilt niches in consumer health software. The published critiques converge on a small set of structural failures: phenotype-incorrect onboarding, collapsed severity scoring, ignored ocular phenotype, no skin-tone-equity work, and photo pipelines that fail serial comparability. This is the category-level argument for why a new entrant is worth building.
Article · May 28, 2026
The canonical NRS 2002 trigger list is a great patient-survey dataset and it is also missing the largest single new rosacea-trigger event of the last decade. A 34 percent post-COVID exacerbation rate in one retrospective study and a 28.8 percent post-infection rate in a 2025 cross-sectional study describe a trigger pattern the 2002 framing has no field for.
Article · May 28, 2026
Auto white balance is explicitly discouraged in serial clinical photography. Flash creates specular hotspots that destroy erythema scoring. Standardized lighting, manual white-balance lock, fixed distance, dark blue background for skin of color: these are not opinions. They are the published protocol. Almost no consumer dermatology app implements any of them. The result is a photo set you cannot serially compare.
Article · May 28, 2026
Rosacea patients have roughly 8 times the Demodex mite density of healthy controls. Topical ivermectin, which kills the mites, reduces rosacea lesions in randomized trials. The mites are there, the treatment that targets them works, and the causal story is still being worked out. We are going to explain what the literature actually says and what it doesn't, in plain language, without recommending you do anything beyond bring this up with your dermatologist.
Article · May 28, 2026
Postmenopausal patients sometimes report their rosacea getting better, not worse, when the literature might predict the opposite. The Nurses' Health Study II analysis on exogenous hormones found that menopausal hormone therapy and oral contraceptives are dose-responsively associated with increased incident rosacea risk. Both findings line up with an estrogen-modulated mechanism dermatology has been quietly working out for years.
Article · May 28, 2026
Two separate strands of rosacea-and-alcohol research disagree at first glance, then reconcile in a way that matters at a wedding dinner. The NRS 2010 acute-flushing survey put red wine far ahead of white as a trigger. The Li 2017 NHS cohort found white wine and liquor associated with incident rosacea risk and red wine, not statistically associated. The disagreement is real, and the two findings are about different things.
Article · May 28, 2026
Most rosacea patients learn from forum lore that they have to give up coffee. The published evidence is the opposite. A case-control study found that 60°C water and 60°C coffee produced equivalent flushing, and both at 22°C did not. A 82,737-woman cohort showed caffeine intake is inversely associated with incident rosacea risk. The trigger is the heat, not the chemistry.
Article · May 28, 2026
The published preferences are clear and the consumer-app category has mostly ignored them. Dermatologists want a single-page summary with the flare count, the top trigger co-occurrences, two photos, and the quality-of-life trend. They explicitly do not want 90 daily photos, a dashboard URL, or a pseudo-diagnostic score the patient pulled off an app. The 12-minute visit makes this concrete.
Article · May 28, 2026
Ocular involvement affects 50 to 72 percent of cutaneous rosacea patients, and in a meaningful subset it shows up before the facial component does. The 2017 phenotype framework lists ocular manifestations as a major phenotype, on its own line, with diagnostic weight. Most rosacea trackers don't have a field for it.
Article · May 28, 2026
Patients complain that their tracker's single severity number doesn't reflect what their face is actually doing. It turns out that complaint matches a published critique of the Investigator Global Assessment scale that dermatology has been working with for years. The collapse-into-one-number problem is structural, not a UX bug.
Article · May 28, 2026
Reported rosacea prevalence in Fitzpatrick IV-V skin sits at roughly 6 to 8 percent of the rosacea-diagnosed population. The literature is explicit that a meaningful share of that gap is diagnostic masking, not biology. Telangiectasia is harder to see against pigmented skin, and the dermatology image-classification models trained to spot it perform 3 times worse on darker skin than on lighter. We built Skinframe to not make that mistake worse.
Article · May 28, 2026
In 2017, the dermatology field formally retired the four-subtype rosacea model and replaced it with a phenotype framework. Nine years later, every rosacea-named tracker on the App Store still opens with "which type of rosacea do you have?" That question has a name in the literature, and the literature has moved on.